ML-B01

ML-B01 is a potent, orally bioavailable dual inhibitor of Akt (IC50=2 nM) and PKA (IC50=136 nM) . Its demonstrated blood-brain barrier permeability in mice supports its utility for in vivo research, particularly in studying central nervous system cancers and signaling pathways.